Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04517695 · ClinicalTrials.gov registry record

Blood Volume Assessment in COVID-19 and Bacterial Sepsis

A clinical trial of Covid19 and Acute Respiratory Distress Syndrome, sponsored by NYU Langone Health.

Completed
Registry status
39
Enrollment target
3
Study locations

NCT04517695 is a study of Covid19 and Acute Respiratory Distress Syndrome that has completed, run by NYU Langone Health. The registered enrollment target is 39 participants, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04517695, a study of Covid19 and Acute Respiratory Distress Syndrome, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
39 participants
Enrollment target
3
Study locations

Study Summary

In patients with SARS-CoV-2 or bacterial infection admitted to the intensive care unit (ICU), the state of the intravascular volume, the characteristics of the blood volume components, and the development of a vascular leak is currently unknown. The relationship of these parameters with parameters of cardiac performance, lung edema and sublingual microcirculatory perfusion parameters have never been studied.

Conditions Studied

Covid19 Acute Respiratory Distress Syndrome Bacterial Infections Bacterial Sepsis

Interventions

  • DEVICE BVA-100
  • DEVICE Transpulmonary Thermodilution (TPTD)
  • DEVICE Sublingual Microcirculation

Study Locations (3)

Maryland

  • Uniformed Services University of the Health Sciences - Bethesda

New York

  • NYU Langone Health - New York

North Carolina

  • Wake Forest Baptist Health - Winston-Salem

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2020-08-01
Est. Completion 2023-04-09

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04517695

The ClinicalTrials.gov registry entry for NCT04517695 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (99% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Covid19 appearing as the primary indexed condition, and to 3 interventions - of which BVA-100 is the first listed.

NCT04517695 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, New York, North Carolina.

Frequently Asked Questions

What is clinical trial NCT04517695 about?

NCT04517695 is a clinical study titled "Blood Volume Assessment in COVID-19 and Bacterial Sepsis". In patients with SARS-CoV-2 or bacterial infection admitted to the intensive care unit (ICU), the state of the intravascular volume, the characteristics of the blood volume components, and the development of a vascular leak is currently unknown. The relationship of these parameters with parameters o...

What is the current status of trial NCT04517695?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2020-08-01. Estimated completion is 2023-04-09.

What conditions does trial NCT04517695 study?

This clinical trial studies the following conditions: Covid19, Acute Respiratory Distress Syndrome, Bacterial Infections, Bacterial Sepsis.

What interventions are being tested in trial NCT04517695?

The interventions under investigation include: BVA-100 (DEVICE), Transpulmonary Thermodilution (TPTD) (DEVICE), Sublingual Microcirculation (DEVICE).

Who is sponsoring clinical trial NCT04517695?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04517695 being conducted?

This trial has 3 study locations across Maryland, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Covid19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Covid19

All registered trials for this condition

Acute Respiratory Distress Syndrome

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.